Induction of apoptosis in primary meningioma cultures by fenretinide.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer Research

• Publication date

  2005-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-04-0786PMID 15735044
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma.

  2003cited by this paper
• Antitumor activity of the growth hormone receptor antagonist pegvisomant against human meningiomas in nude mice.

  2001cited by this paper
• Mechanism of fenretinide (4-HPR)-induced cell death

  2001cited by this paper
• Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells.

  2000cited by this paper
• 2000 World Health Organization classification of tumors of the nervous system.

  2000cited by this paper
• Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.

  2000cited by this paper
• Mitochondrial permeability transition is a central coordinating event in N-(4-hydroxyphenyl)retinamide-induced apoptosis.

  2000cited by this paper
• Induction of apoptosis by N-(4-hydroxyphenyl)retinamide and its association with reactive oxygen species, nuclear retinoic acid receptors, and apoptosis-related genes in human prostate carcinoma cells.

  1999cited by this paper
• Implication of mitochondria-derived reactive oxygen species, cytochrome C and caspase-3 in N-(4-Hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells

  1999cited by this paper
• Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines.

  1999cited by this paper
• Growth hormone receptor expression and function in meningiomas: effect of a specific receptor antagonist.

  1999cited by this paper
• Specific retinoid receptors cooperate to signal growth suppression and maturation of human embryonal carcinoma cells

  1998cited by this paper
• Chemoprevention Trial of Contralateral Breast Cancer with Fenretinide. Rationale, Design, Methodology, Organization, Data Management, Statistics and Accrual

  1997cited by this paper
• Phase II chemoprevention trial of oral fenretinide in patients at risk for adenocarcinoma of the prostate.

  1997cited by this paper
• Epidemiology and etiology of intracranial meningiomas: A review

  1996cited by this paper
• The biology of meningiomas

  1996cited by this paper
• Chemotherapy for meningiomas

  1996cited by this paper
• 4-Hydroxyphenyl Retinamide Is a Highly Selective Activator of Retinoid Receptors*

  1996cited by this paper
• N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma.

  1995cited by this paper
• Vitamin A, differentiation and cancer.

  1994cited by this paper
• Response and resistance to retinoic acid are mediated through the retinoic acid nuclear receptor gamma in human teratocarcinomas.

  1994cited by this paper
• Phase IIa study of fenretinide in superficial bladder cancer, using DNA flow cytometry as an intermediate end point.

  1994cited by this paper
• Expression of insulin-like growth factors and their receptors in human meningiomas

  1993cited by this paper
• N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid.

  1993cited by this paper
• The synthetic retinoid fenretinide lowers plasma insulin-like growth factor I levels in breast cancer patients.

  1993cited by this paper
• Expression of insulin‐like growth factors I and II and their receptor mRNAs in primary human astrocytomas and meningiomas; in vivo studies using in situ hybridization and immunocytochemistry

  1992cited by this paper
• Effects of Meals and Meal Composition on the Bioavailability of Fenretinide

  1992cited by this paper
• Characterization of insulin-like growth factor I and epidermal growth factor receptors in meningioma.

  1989cited by this paper
• An overview of the retinoids.

  1989cited by this paper

• Establishment of a patient-derived 3D in vitro meningioma model in xeno-free hydrogel for clinical applications

  2025cites this paper
• MUC4 and Caspase-3 Immunoexpression in Meningioma: A Histopathological Study Linking Mucin & Apoptotic Pathways.

  2025cites this paper
• Risk of intracranial meningioma in patients with acromegaly: a systematic review

  2024cites this paper
• A New Strategy for Obesity Treatment: Revealing the Frontiers of Anti-obesity Medications.

  2024cites this paper
• Caspase 3 Expression Profiles in Meningioma Subtypes Based on Tissue Microarray Analysis

  2024cites this paper
• Preclinical Models of Meningioma.

  2023cites this paper
• Drug target therapy and emerging clinical relevance of exosomes in meningeal tumors

  2023cites this paper
• Modeling Meningiomas: Optimizing Treatment Approach.

  2023cites this paper
• Caspase 8 Expression Patterns in Meningiomas: A Tissue Microarray Digital Image Analysis

  2022cites this paper
• The role of aquaporin 4 in brain tumors: implications for pathophysiology, diagnosis and therapy

  2022cites this paper
• High Grade Meningiomas: Current Therapy Based on Tumor Biology

  2021cites this paper
• An Overview of Managements in Meningiomas

  2020cites this paper
• Pharmacotherapeutic options for atypical meningiomas

  2019cites this paper
• Expression, correlation and prognostic significance of CD133, P57 and HSF1 in meningioma.

  2017cites this paper
• Design of Controlled Release PLGA Microspheres for Hydrophobic Fenretinide.

  2016cites this paper
• An audit of immunohistochemical marker patterns in meningioma.

  2014cites this paper
• Caspase-3 and Survivin Expression in Primary Atypical and Malignant Meningiomas

  2013cites this paper
• Recent developments in chemotherapy for meningiomas: a review.

  2013cites this paper
• CD133-Positive Cells Might Be Responsible for Efficient Proliferation of Human Meningioma Cells

  2012cites this paper
• Pathological classification and molecular genetics of meningiomas

  2010cites this paper
• Angioprevention with fenretinide: targeting angiogenesis in prevention and therapeutic strategies.

  2010cites this paper
• Antigen expression on recurrent meningioma cells

  2010cites this paper
• CHAPTER 56 – Chemotherapy and Experimental Medical Therapies for Meningiomas

  2010cites this paper
• Medical therapies for meningiomas

  2010cites this paper
• YY1 Over-Expression in Human Brain Gliomas and Meningiomas Correlates with TGF-β1, IGF-1 and FGF-2 mRNA Levels

  2009cites this paper
• p‐Dodecylaminophenol derived from the synthetic retinoid, fenretinide: Antitumor efficacy in vitro and in vivo against human prostate cancer and mechanism of action

  2008cites this paper
• CAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction is a major component of SHetA2-induced apoptosis in lung cancer cells.

  2008cites this paper
• Potent anticancer activities of novel aminophenol analogues against various cancer cell lines.

  2007cites this paper
• Irinotecan: a potential new chemotherapeutic agent for atypical or malignant meningiomas.

  2007cites this paper
• Apoptosis in brain tumors: prognostic and therapeutic considerations.

  2007cites this paper
• Nelfinavir potentiation of imatinib cytotoxicity in meningioma cells via survivin inhibition.

  2007cites this paper
• Fenretinide upregulates DR 5 / TRAIL-R 2 expression via the induction of the transcription factor CHOP and combined treatment with fenretinide and TRAIL induces synergistic apoptosis in colon cancer cell lines

  2007cites this paper
• Novel cell death pathways induced by N-(4-hydroxyphenyl)retinamide: therapeutic implications

  2007cites this paper
• Role of Merlin in the Growth and Transformation of Arachnoidal Cells

  2007cites this paper
• Functional Properties of Carotenoids in Human Health

  2007cites this paper
• Fenretinide up-regulates DR5/TRAIL-R2 expression via the induction of the transcription factor CHOP and combined treatment with fenretinide and TRAIL induces synergistic apoptosis in colon cancer cell lines.

  2007cites this paper
• Targeted drug therapy for meningiomas.

  2007cites this paper
• Antioxidant and anticancer activities of novel p-alkylaminophenols and p-acylaminophenols (aminophenol analogues).

  2006cites this paper
• Amphiphilic poly(vinyl alcohol) derivatives as complexing agents for fenretinide.

  2006cites this paper
• Histological classification and molecular genetics of meningiomas.

  2006cites this paper
• Novel therapies for meningiomas

  2006cites this paper
• A genetic strategy to overcome the senescence of primary meningioma cell cultures

  2006cites this paper
• Mechanisms of fenretinide-induced apoptosis

  2006cites this paper
• Chemopreventive agent-induced modulation of death receptors

  2005cites this paper
• Neuro-Oncology in a Nutshell

  2004cites this paper
• Functional connectivity in presymptomatic juveniles with the gene expansion for Huntington’s Disease

  year unknowncites this paper
• Iranian Journal of Basic Medical Sciences Survival, Proliferation, and Migration of Human Meningioma Stem-like Cells in a Nanopeptide Scaffold Introduction

  year unknowncites this paper